Description
KYMORIV-D — A Four-Way Combination for Rapid Pain, Swelling and Inflammation Relief
KYMORIV-D combines Trypsin 48 mg, Bromelain 90 mg, Rutoside Trihydrate 100 mg and Diclofenac Sodium 50 mg in a single tablet that addresses inflammation from multiple angles. Trypsin and Bromelain are proteolytic enzymes recognised for helping reduce swelling and accelerate tissue repair, Rutoside Trihydrate supports capillary strength and helps manage edema, while Diclofenac Sodium provides fast-acting analgesic and anti-inflammatory action as an NSAID. This layered approach makes KYMORIV-D relevant for post-traumatic and post-surgical swelling, musculoskeletal pain and inflammatory conditions where faster resolution of swelling matters as much as pain relief, giving franchise partners a genuinely differentiated combination for their pain-management range.
Combination Precision Backed by Certified Manufacturing
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. Combining proteolytic enzymes with a bioflavonoid and an NSAID in one tablet requires precise formulation to keep all four actives stable and consistently bioavailable and KYMORIV-D is manufactured under strict quality control to maintain this reliability across every batch. For a PCD pharma franchise company in India, offering a well-formulated enzyme-NSAID combination gives field partners a strong product to introduce to orthopaedic surgeons, dentists and general physicians managing post-injury or post-surgical inflammation.
Product Highlights for Franchise Partners
- Composition: Trypsin 48 mg + Bromelain 90 mg + Rutoside Trihydrate 100 mg + Diclofenac Sodium 50 mg
- Dosage Form: Tablets
- Pack Size: 10 X 10
- Pack Type: ALU ALU for enhanced stability and shelf protection
- Key Benefit: Rapid relief from pain, swelling and inflammation
- Suited For: Distributors and medical representatives strengthening their pain-management range
Franchise partners looking to add a comprehensive anti-inflammatory combination to their portfolio can explore this and other formulations through our PCD pharma franchise division, with complete promotional support.
Disclaimer: This is a prescription product and should be used strictly under the guidance of a registered medical practitioner.
